Clinical Trial Update: Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 trial update evaluating de-escalation of radiotherapy to 30 Gy for select HPV-associated oropharyngeal squamous cell carcinoma. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Squamous Cell Carcinoma
• Squamous Cell Carcinoma of the Neck

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: HPV-Associated Oropharyngeal Squamous Cell Carcinoma, Squamous Cell Carcinoma of the Neck | Phase 2 | Status: ACTIVE_NOT_RECRUITING